Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?
Journal of Infection and Public Health · 2024
DOI: 10.1016/j.jiph.2024.102512 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Infection and Public Health, 2024. Verfasst von Line Lundegaard Bang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Odense University Hospital, and Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, …. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Antibodies, Monoclonal, Humanized, Antibodies, Neutralizing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region of Southern Denmark.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microbiology, Odense University Hospital, and Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, Denmark. Electronic address: llbang@health.sdu.dk.
- Department of Infectious Diseases, Odense University Hospital and Research Unit for Infectious Diseases, University of Southern Denmark, Odense, Denmark; Unit for Infectious Diseases, Department of Medicine, Sygehus Lil…
- Department of Clinical Microbiology, Odense University Hospital, and Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, Denmark. Electronic address: rune.pedersen@rsyd.dk.
- Department of Clinical Immunology, Odense University Hospital, and Research Unit for Clinical Immunology, University of Southern Denmark, Odense, Denmark. Electronic address: christine.nilsson@rsyd.dk.
- Department of Infectious Diseases, Odense University Hospital and Research Unit for Infectious Diseases, University of Southern Denmark, Odense, Denmark. Electronic address: Isik.Somuncu.Johansen@rsyd.dk.
- Department of Clinical Microbiology, Odense University Hospital, and Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark. Electronic address: thandersen@health.sdu.dk.
Förderung
- Region of Southern Denmark
Zitieren
APA
Bang, L. L., Madsen, L. W., Pedersen, R. M., Nilsson, A. C., Johansen, I. S., & Andersen, T. E. (2024). Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.102512
Vancouver
Bang LL, Madsen LW, Pedersen RM, Nilsson AC, Johansen IS, Andersen TE. Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.102512
BibTeX
@article{Bang2024,
author = {Bang, Line Lundegaard and Madsen, Lone Wulff and Pedersen, Rune Micha and Nilsson, Anna Christine and Johansen, Isik Somuncu and Andersen, Thomas Emil},
title = {Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?},
journal = {Journal of Infection and Public Health},
year = {2024},
doi = {10.1016/j.jiph.2024.102512}
}
EUVIMED